{"id":1633,"date":"2017-01-17T09:01:04","date_gmt":"2017-01-17T14:01:04","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1633"},"modified":"2017-01-17T10:26:39","modified_gmt":"2017-01-17T15:26:39","slug":"flurry-of-filings-post-mlk-day-six-companies-launch-for-ipo-on-tuesday-1-17-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/flurry-of-filings-post-mlk-day-six-companies-launch-for-ipo-on-tuesday-1-17-17\/","title":{"rendered":"Flurry of Filings post MLK Day – Seven Companies Launch for IPO on Tuesday (1.17.17)"},"content":{"rendered":"

The syndicate market was very active following the MLK holiday as six companies filed terms with the SEC. Among the seven, four are healthcare companies, one is materials, one is industrial and another is an energy company. These six will debut next week in addition to the first technology deal of 2017, AppDynamics (Nasdaq: APPD).<\/a>\u00a0<\/strong>IPO Boutique provides comprehensive research, daily advisories and ratings on\u00a0EVERY IPO<\/strong>.<\/p>\n

Indicate with confidence — subscribe to IPO Boutique.<\/a><\/strong><\/h3>\n

TERMS ADDED on TUESDAY (1.17.17)<\/h2>\n

Company: ObsEva, Inc<\/strong>
\nSymbol: OBSV
\nPrice: $14.00-$16.00
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.
\nTrade Date: 1\/26
\nShares: 6.5 million
\nUnderwriter(s): Credit Suisse, Jefferies, Leerink Partners
\nCo Manager(s): N\/A<\/p>\n

Company: AnaptysBio, Inc.<\/strong>
\nSymbol: ANAB
\nPrice: $14.00-$16.00
\nDescription: They are a biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
\nTrade Date: 1\/26
\nShares: 4 million
\nUnderwriter(s): Credit Suisse, Stifel
\nCo Manager(s): JMP Securities, Wedbush PacGrow<\/p>\n

Company: Jounce Therapeutics<\/strong>
\nSymbol: JNCE
\nPrice: $13.00-$15.00
\nDescription: They are a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
\nTrade Date: 1\/27
\nShares: 5.4 million
\nUnderwriter(s): J.P. Morgan, Cowen & Company
\nCo Manager(s): Wells Fargo Securities, Baird<\/p>\n

Company: Jagged Peak Energy<\/strong>
\nSymbol: JAG
\nPrice: $16.00-$18.00
\nDescription: They are a growth-oriented, independent oil and natural gas company focused on the acquisition and development of unconventional oil and associated liquids-rich natural gas reserves in the Southern Delaware Basin, a sub-basin of the Permian Basin of West Texas and one of the most prolific unconventional resource plays in North America.
\nTrade Date: 1\/27
\nShares: 38.2 million
\nUnderwriter(s): Citigroup, Credit Suisse, J.P. Morgan, Goldman Sachs & Co., RBC Capital Markets, Wells Fargo Securities
\nCo Manager(s): UBS Investment Bank, KeyBanc Capital Markets, ABN AMRO, Fifth Third Securities, Petrie Partners Securities, Tudor Pickering, Holt & Co., BMO Capital Markets, Deutsche Bank Securities, Evercore ISI, Scotia Howard Weil<\/p>\n

Company: JELD-WEN Holding<\/strong>
\nSymbol: JELD
\nPrice: $21.00-$23.00
\nDescription: They are one of the world\u2019s largest door and window manufacturers, and they hold the #1 position by net revenues in the majority of the countries and markets they serve.
\nTrade Date: 1\/27
\nShares: 25 million
\nUnderwriter(s): Barclays, Citigroup, Credit Suisse, J.P. Morgan, Deutsche Bank Securities, RBC Capital Markets, BofA Merrill Lynch, Goldman Sachs & Co., Wells Fargo Securities
\nCo Manager(s): Baird, FBR, SunTrust Robinson Humphrey<\/p>\n

Company: Visterra, Inc.<\/strong>
\nSymbol: VIST
\nPrice: $12.00-$14.00
\nDescription: They are a clinical-stage biopharmaceutical company focused on applying their novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration.
\nTrade Date: 1\/27
\nShares: 3.9 million
\nUnderwriter(s): Leerink Partners, Stifel
\nCo Manager(s): Needham & Company, Wedbush PacGrow<\/p>\n

Company: REV Group<\/strong>
\nSymbol: REV
\nPrice: $19.00-$21.00
\nDescription: REV is a leading designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services.
\nTrade Date: 1\/27
\nShares: 12.5 million
\nUnderwriter(s): Goldman Sachs & Co., Morgan Stanley, Baird
\nCo Manager(s): BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, Jefferies, Wells Fargo Securities, Stifel<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The syndicate market was very active following the MLK holiday as six companies filed terms with the SEC. Among the seven, four are healthcare companies, one is materials, one is industrial and another is an energy company. These six will debut next week in addition to the first technology deal of 2017, AppDynamics (Nasdaq: APPD).\u00a0IPO[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,985],"tags":[1019,992,1016,986,1018,1020,1017],"class_list":["post-1633","post","type-post","status-publish","format-standard","hentry","category-ipo","category-news","tag-anab","tag-jag","tag-jeld","tag-jnce","tag-obsv","tag-rev","tag-vist"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1633"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1633\/revisions"}],"predecessor-version":[{"id":1640,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1633\/revisions\/1640"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}